1 Study Coverage

• 1.1 Ponatinib Product Introduction
• 1.2 Market Segments
• 1.3 Key Ponatinib Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Ponatinib Market Size Growth Rate by Type
  • 1.4.2 45mg
  • 1.4.3 15mg
• 1.5 Market by Application
  • 1.5.1 Global Ponatinib Market Size Growth Rate by Application
  • 1.5.2 CML
  • 1.5.3 ALL
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Ponatinib Market Size, Estimates and Forecasts
  • 2.1.1 Global Ponatinib Revenue 2015-2026
  • 2.1.2 Global Ponatinib Sales 2015-2026
• 2.2 Global Ponatinib, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Ponatinib Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Ponatinib Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ponatinib Competitor Landscape by Players

• 3.1 Ponatinib Sales by Manufacturers
  • 3.1.1 Ponatinib Sales by Manufacturers (2015-2020)
  • 3.1.2 Ponatinib Sales Market Share by Manufacturers (2015-2020)
• 3.2 Ponatinib Revenue by Manufacturers
  • 3.2.1 Ponatinib Revenue by Manufacturers (2015-2020)
  • 3.2.2 Ponatinib Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Ponatinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Ponatinib Revenue in 2019
  • 3.2.5 Global Ponatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Ponatinib Price by Manufacturers
• 3.4 Ponatinib Manufacturing Base Distribution, Product Types
  • 3.4.1 Ponatinib Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Ponatinib Product Type
  • 3.4.3 Date of International Manufacturers Enter into Ponatinib Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Ponatinib Market Size by Type (2015-2020)
  • 4.1.1 Global Ponatinib Sales by Type (2015-2020)
  • 4.1.2 Global Ponatinib Revenue by Type (2015-2020)
  • 4.1.3 Ponatinib Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Ponatinib Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Ponatinib Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Ponatinib Revenue Forecast by Type (2021-2026)
  • 4.2.3 Ponatinib Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Ponatinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Ponatinib Market Size by Application (2015-2020)
  • 5.1.1 Global Ponatinib Sales by Application (2015-2020)
  • 5.1.2 Global Ponatinib Revenue by Application (2015-2020)
  • 5.1.3 Ponatinib Price by Application (2015-2020)
• 5.2 Ponatinib Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Ponatinib Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Ponatinib Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Ponatinib Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Ponatinib by Country
  • 6.1.1 North America Ponatinib Sales by Country
  • 6.1.2 North America Ponatinib Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Ponatinib Market Facts & Figures by Type
• 6.3 North America Ponatinib Market Facts & Figures by Application

7 Europe

• 7.1 Europe Ponatinib by Country
  • 7.1.1 Europe Ponatinib Sales by Country
  • 7.1.2 Europe Ponatinib Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Ponatinib Market Facts & Figures by Type
• 7.3 Europe Ponatinib Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Ponatinib by Region
  • 8.1.1 Asia Pacific Ponatinib Sales by Region
  • 8.1.2 Asia Pacific Ponatinib Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Ponatinib Market Facts & Figures by Type
• 8.3 Asia Pacific Ponatinib Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Ponatinib by Country
  • 9.1.1 Latin America Ponatinib Sales by Country
  • 9.1.2 Latin America Ponatinib Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Ponatinib Market Facts & Figures by Type
• 9.3 Central & South America Ponatinib Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Ponatinib by Country
  • 10.1.1 Middle East and Africa Ponatinib Sales by Country
  • 10.1.2 Middle East and Africa Ponatinib Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Ponatinib Market Facts & Figures by Type
• 10.3 Middle East and Africa Ponatinib Market Facts & Figures by Application

11 Company Profiles

• 11.1 ARIAD Pharmaceuticals
  • 11.1.1 ARIAD Pharmaceuticals Corporation Information
  • 11.1.2 ARIAD Pharmaceuticals Description and Business Overview
  • 11.1.3 ARIAD Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 ARIAD Pharmaceuticals Ponatinib Products Offered
  • 11.1.5 ARIAD Pharmaceuticals Related Developments
• 11.1 ARIAD Pharmaceuticals
  • 11.1.1 ARIAD Pharmaceuticals Corporation Information
  • 11.1.2 ARIAD Pharmaceuticals Description and Business Overview
  • 11.1.3 ARIAD Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 ARIAD Pharmaceuticals Ponatinib Products Offered
  • 11.1.5 ARIAD Pharmaceuticals Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Ponatinib Market Estimates and Projections by Region
  • 12.1.1 Global Ponatinib Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Ponatinib Revenue Forecast by Regions 2021-2026
• 12.2 North America Ponatinib Market Size Forecast (2021-2026)
  • 12.2.1 North America: Ponatinib Sales Forecast (2021-2026)
  • 12.2.2 North America: Ponatinib Revenue Forecast (2021-2026)
  • 12.2.3 North America: Ponatinib Market Size Forecast by Country (2021-2026)
• 12.3 Europe Ponatinib Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Ponatinib Sales Forecast (2021-2026)
  • 12.3.2 Europe: Ponatinib Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Ponatinib Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Ponatinib Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Ponatinib Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Ponatinib Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Ponatinib Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Ponatinib Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Ponatinib Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Ponatinib Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Ponatinib Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Ponatinib Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Ponatinib Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Ponatinib Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Ponatinib Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Ponatinib Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Ponatinib Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Ponatinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ponatinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ponatinib market is segmented into
45mg
15mg

Segment by Application, the Ponatinib market is segmented into
CML
ALL

Regional and Country-level Analysis
The Ponatinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ponatinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ponatinib Market Share Analysis
Ponatinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ponatinib business, the date to enter into the Ponatinib market, Ponatinib product introduction, recent developments, etc.

The major vendors covered:
ARIAD Pharmaceuticals
...